Most Popular

These content links are provided by Content.ad. Both Content.ad and the web site upon which the links are displayed may receive compensation when readers click on these links. Some of the content you are redirected to may be sponsored content. View our privacy policy here.

To learn how you can use Content.ad to drive visitors to your content or add this service to your site, please contact us at [email protected].

Family-Friendly Content test

Website owners select the type of content that appears in our units. However, if you would like to ensure that Content.ad always displays family-friendly content on this device, regardless of what site you are on, check the option below. Learn More


John Roberts, the Fox News presenter, is retaliating after the Biden campaign called him out for disseminating a “blatant lie.”

The Biden team is fond of reminding people that President Joe Biden set a $35 maximum price for Medicare-eligible Americans to purchase insulin. However, Roberts undermined the Biden campaign’s narrative this week by reminding Fox News viewers that then-President Trump initially implemented the $35 price restriction in 2020.

“Receipts contradict the Biden campaign’s assertion regarding my remarks.”

“Maybe I’m misremembering that, but I believe it kind of already happened,” Roberts replied.

The Biden campaign asserted on Monday that Roberts had lied.

This is an outright falsehood. The campaign stated, “President Biden capped insulin costs for seniors through the Inflation Reduction Act; Trump did not.” “Trump’s Project 2025 wants to repeal it, which would increase insulin costs for over a million Americans.”

It turns out that Roberts is not the one disseminating incorrect information, it is the Biden campaign.

Roberts responded to the accusation from the Biden campaign on Tuesday.

Roberts cited receipts that refuted the Biden campaign’s assertion regarding his remarks.

First, Roberts referenced a news statement announcing the Trump policy from the Centers for Medicare & Medicaid Services in May 2020. According to the press release, Medicare recipients will have access to a wide range of insulins at a maximum payment of $35 for a month’s supply under the Trump program.

Second, Roberts mentioned Tracey Brown, the then-CEO of the American Diabetes Association, who attended a Rose Garden ceremony where Trump announced his policy. Roberts showed a video of Brown praising Trump for providing insulin to Americans in need. Furthermore, Roberts clarified that he was present during the Rose Garden ceremony.

Third, Roberts cited a Washington Post article about Trump’s policies.

At the time, the publication stated:

“The White House has brokered an agreement with insulin manufacturers and some Medicare plans that would decrease costs for some seniors starting in 2021 by capping co-pays at $35 per month — a figure that administration officials said would mean roughly a two-thirds lowering in out-of-pocket money and would help seniors continue taking insulin.”

In conclusion, Roberts referenced a study from the left-wing research tank Rand Corporation endorsing Trump’s initiative.

“We invited a representative from the Biden campaign to come on the program with us to discuss the issue, but thus far they have made no one available,” Roberts said.

The fact that Executive Directive 13937, another Trump directive, was created to reduce the cost of insulin was something Roberts omitted from his statement. Later, Biden revoked it, and the Inflation Reduction Act included essentially the same $35 insulin price cap created by the Trump administration.

Author: Steven Sinclaire

Most Popular

These content links are provided by Content.ad. Both Content.ad and the web site upon which the links are displayed may receive compensation when readers click on these links. Some of the content you are redirected to may be sponsored content. View our privacy policy here.

To learn how you can use Content.ad to drive visitors to your content or add this service to your site, please contact us at [email protected].

Family-Friendly Content

Website owners select the type of content that appears in our units. However, if you would like to ensure that Content.ad always displays family-friendly content on this device, regardless of what site you are on, check the option below. Learn More



Most Popular
Sponsored Content

These content links are provided by Content.ad. Both Content.ad and the web site upon which the links are displayed may receive compensation when readers click on these links. Some of the content you are redirected to may be sponsored content. View our privacy policy here.

To learn how you can use Content.ad to drive visitors to your content or add this service to your site, please contact us at [email protected].

Family-Friendly Content

Website owners select the type of content that appears in our units. However, if you would like to ensure that Content.ad always displays family-friendly content on this device, regardless of what site you are on, check the option below. Learn More

Comments are closed.

Ad Blocker Detected!

Advertisements fund this website. Please disable your adblocking software or whitelist our website.
Thank You!